Arkema Sa · EURONEXT:AKE

Arkema Sa — Shareholder Meeting (June 2013)

49 slides from Arkema Sa's shareholder meeting presentation, Jun 4, 2013

  1. Slide 1: 2013 Annual General Meeting

    2013 Annual General Meeting June 4th, 2013

  2. Slide 2: 2012 Highlights

    2012 Highlights

  3. Slide 3: Arkema in 2012

    Arkema in 2012 13,925 1,200 € 6.4 bn employees researchers sales 91 10 € 996 m production sites R&D centers EBITDA Presence 151 € 438 m in 40 countries patent applications capex 3

  4. Slide 4: Three specialty segments

    Three specialty segments High Performance Materials Coating Solutions Sales by segment World of high value and Solutions for decorative paints, innovative solutions industrial coatings and high-growth acrylic applications 33 % 34 % 33 % Industrial Specialties Global and integrated industrial niches

  5. Slide 5: New corporate image

    New corporate image Targeted growth focused on specialties Innovation at the heart of Arkema’s strategy A new signature : « Innovative chemistry » 5

  6. Slide 6: Among top players on 90% of sales

    Among top players on 90 % of sales POSITION % of sales Specialty Polyamides (10, 11 and 12) #1 14% Fluoropolymer (PVDF) #1 Organic Peroxides #2 9% Thiochemicals #1 9% Fluorogases #2 10% PMMA #2 10% Hydrogen Peroxide #3 4% Acrylic monomers #4 13% Coating Resins #3 13% UV-curing Resins #2 5% 6 High Pe

  7. Slide 7: Balanced geographical presence

    Balanced geographical presence Europe 47 production sites 34% of sales 6 R&D centers North America 40% of sales 26 production sites 2 R&D centers 5% of sales 21% of sales Rest of the World Asia 5 production sites 13 production sites 2 R&D centers HIGH GROWTH COUNTRIES 7

  8. Slide 8: A strong footprint in France

    A strong footprint in France Capex: € 208 m in 2012 (47% of Group’s capex) Workforce: 48% of Group’s employees 75% of Group’s R&D effort • 6 R&D centers, 900 researchers • Research partnerships with Aquitaine region, CNRS, CEA and competitiveness clusters (Axelera, etc.) 23 production sites in Franc

  9. Slide 9: Diversified end markets

    Diversified end markets Others 8% 22% Consumer goods Health, hygiene and beauty, wellness, sports and leasure, packaging, textile, etc. 16% Chemical and plastic industry Water 3% Electronics 3% 13% Nutrition 4% Industrial coatings 6% Construction 6% 12% Energy 7% Decorative paints Transportation 9

  10. Slide 10: Innovation at the heart of the strategy

    Innovation at the heart of the strategy 10 R&D centers 1,200 researchers ~€ 150 m budget 2.3 % of sales Unique technology expertise New R&D center in Changshu (China) opened beginning 2013 Close proximity with customers Long-term breakthrough projects supported by corporate R&D 10

  11. Slide 11: Safety and environmental performance

    Safety and environmental performance Total recordable injury rate Greenhouse Gas Emissions (million working hours) (mT CO2 eq.) 13.3 8.3 5.1 3.4 2005 2012 2005 2012 Our ambition: be a top quartile Our ambition: reduce environmental performer in safety in the chemical footprint of our activities indu

  12. Slide 12: Thiochemical platform in Malaysia

    Thiochemical platform in Malaysia Kerteh Project in partnership with South Korean company CJ CheilJedang Ground breaking ceremony in October 2012 Capex for Arkema’s Thiochemical plant of Arkema: around US$220m Mechanical completion expected beginning of 2014 12

  13. Slide 13: Structure of Thiochemicals project in Malaysia

    Structure of Thiochemicals project in Malaysia CheilJedang 86% 14% 14% 86% Sucrose, starch, Sulfur Thiochemicals JV Bio-methionine JV glycerol Oil, gas, petrochemicals Animal nutrition 13

  14. Slide 14: Capex program in Acrylics in North America

    Capex program in Acrylics in North America Capex: US$ 110 m Two units already started: • 2EHA: new unit started in 2012 in Bayport • Acrylic Acid: capacity increase in Clear Lake started end of May 2013 (+60 kT with half of production for methyl acrylate) Under construction in Clear Lake (unit acqui

  15. Slide 15: Integration of Hipro and Casda

    Integration of Hipro and Casda Companies acquired in February 2012 (specialized in sebacic acid and polyamide 10) Unique range of specialty polyamides 10, 11 and 12 Global leader for bio-sourced polyamides Trebling polyamide 10 capacity of Hipro (started in 1st quarter 2013) Hengshui (Casda) Zhangji

  16. Slide 16: Divestment of vinyl activities

    Divestment of vinyl activities Divestment of vinyl activities to Klesch group Transaction highlights ● Divestment of a whole coherent portfolio of activities including upstream activities (electrolysis of chlorine, caustic soda and PVC) and downstream activities (compounds, pipes and profiles) ● Aro

  17. Slide 17: Start up of ADAME unit in Carling

    Start up of ADAME™ unit in Carling ADAME™: an acrylic acid derivative End market: water treatment Total capex for Carling modernization: € 40 m 17

  18. Slide 18: New superabsorbent unit in Carling

    New superabsorbent unit in Carling A Sumitomo Seika unit on Arkema’s platform (near 50 kT) Start up expected in 1st half 2013 Superabsorbents: acrylic acid derivatives Project strengthens Carling site End market: diapers 18

  19. Slide 19: Lacq Cluster Chimie 2030 project

    Lacq Cluster Chimie 2030 project Purpose: extend and secure sulfur supply for next 30 years Major turnaround in 4th quarter 2013 Total capex in Lacq for Arkema: € 50 m (including DMDS capacity expansion and large turnaround) 19

  20. Slide 20: Investments in Jarrie

    Investments in Jarrie Conversion of electrolysis to new membrane technology Implementation of Technological Risk Prevention Plan (« PPRT ») Total capex for Jarrie modernization: € 100 m (€ 60 m net with subsidies) 20

  21. Slide 21: PVDF Kynar capacity expansion in Changshu

    PVDF Kynar® capacity expansion in Changshu 50% capacity expansion in July 2012 Following start up of Kynar® PVDF unit in China in 2nd quarter 2011 End markets: new energies, water filtration 21

  22. Slide 22: Acquisition of an industrial site in Brazil

    Acquisition of an industrial site in Brazil Acquisition of an acrylic additives and emulsions site Strengthen Group’s presence in Latin America Combined sales with Coatex in Brazil: US$20 m Araçariguama Rio de Janeiro São Paulo 22

  23. Slide 23: Innovation success

    Innovation success Arkema in the « Top 100 Global Innovator Award 2012 » (Thomson Reuters) • Among the 13 French companies mentioned Pierre Potier prize for Altuglas® ShieldUp • New nano-structured acrylic glass sheet (PMMA) • Outstanding properties: glass replacement • Lightweight material for auto

  24. Slide 24: Financial results

    Financial results

  25. Slide 25: 2012 Key figures

    2012 Key figures In €m (except Earnings Per Share) 2011 2012 variation Sales 5,900 6,395 + 8.4 % EBITDA 1,034 996 - 3.7 % EBITDA margin 17.5 % 15.6 % Recurring operating income 762 678 - 11.0 % Adjusted net income (continuing operations) 574 441 - 23.2 % Adjusted net income (discontinued operations)

  26. Slide 26: +8.4% sales versus 2011

    + 8.4 % sales versus 2011 Sales (€m) FX rate – Scope of translation effect business 6,395 Volume Price + 3.6 % 5,900 + 9.4 % (2.0) % (2.6) % Mainly US$ vs € High basis of Mainly acrylics comparison and fluorogases ● Specialty resins in of 1H’11 1H’12 ● Hipro/Casda (China) ● Alkoxylates ● Divestment

  27. Slide 27: Performance of segments

    Performance of segments Sales (€m) EBITDA (€m) EBITDA margin (%) High Performance Materials 17.2% EBITDA margin, maintained at historical high 2,101 15.3 17.3 17.2 1,952 Strong performance of Technical Polymers 1,680 337 despite slowdown in 4th quarter specifically in Europe 337 361 361 257 2010 201

  28. Slide 28: Capex

    Capex Capex (€m) Strong pipeline of new projects 500 ● Thiochemicals in Malaysia 438 ● Acrylics in the US 365 ● Modernization of Jarrie (France) 265 € 208 m invested in France en 2012 52% of capex dedicated to maintenance, environment and safety 2010 2011 2012 2013e 28

  29. Slide 29: Balance sheet and financing

    Balance sheet and financing Shareholders’ equity € 2.3 bn Rating Net debt € 900 m Standard & Poor’s BBB stable outlook Gearing 39 % Moody’s Baa2 stable outlook Net debt / EBITDA 0.9x € 1.9 bn financing sources (€m) Average maturity > 4 years (€m) 700 500 480 Credit lines 700 980 Bonds 120 Others 100

  30. Slide 30: 1st quarter 2013: a solid start of the year

    1st quarter 2013: a solid start of the year Sales (€m) EBITDA (€m) 1,623 1,563 253 234 Volumes: - 1 % 3rd best performance in a 1st quarter Positive price effect (+ 0.4 %) Significantly above 4th quarter 2012 EBITDA (€ 171 m) 1Q’12 1Q’13 1Q’12 1Q’13 EBITDA (€m) and EBITDA margin (%) by segment 19.1%

  31. Slide 31: Outlook

    Outlook Market conditions remain globally contrasted depending on the regions ● Solid environment in North America ● Continuing challenging environment in Europe, particularly in France and Southern Europe ● Slower than expected growth in Asia but some signs of improvement Priority given to organic

  32. Slide 32: Dividend

    Dividend 1.80 Payout ratio: 25% of adjusted net income 1.3 2.3% dividend yield (based on share price at year end) 1.0 Arkema confirms its target 0.75 announced in September 2012 to 0.6 0.6 reach a 30% payout ratio on adjusted net income. 2007 2008 2009 2010 2011 2012* 32 * Dividend proposed to the S

  33. Slide 33: Corporate Governance

    Corporate Governance

  34. Slide 34: Board of Directors

    Board of Directors Composition ● 11 members ● 9 independent members (82%) in accordance with AFEP-Medef criteria adopted in the internal regulations ● 2 women (18%) • Recommendations issued by Nominating, Compensation and Corporate Governance Committee to reach in 2014 the 20% target set by the 27 J

  35. Slide 35: Renewal of the Board of Directors

    Renewal of the Board of Directors Bernard Kasriel Philippe Vassor Thierry Morin Independent Director Independent Director Independent Director Member of Nominating, Compensation and Chairman of the Audit and Accounts Committee Chairman of Nominating, Compensation Corporate Governance Committee and S

  36. Slide 36: Compensation of Corporate Officers

    Compensation of Corporate Officers Compensation of the Chairman and Chief Executive Officer • 2013 fixed annual compensation: €750,000 • Variable compensation: €1,042,726 due for 2012 • Criteria for variable compensation: • Quantitative targets: 55% EBITDA, 27.5% recurring cash flow and 27.5% margin

  37. Slide 37: Performance shares

    Performance shares Principles of capital-based compensation policy detailed at the beginning of 2013 ● Involve closely the senior managers and certain employees of the Group to its development and its share performance in the medium term ● Gain loyalty and motivate some 700 employees (5% of Group’s

  38. Slide 38: Employees share ownership

    Employees share ownership Objective: associate our employees to the development of the Group Dynamic policy of employees share ownership ● Plans proposed every two years ● To employees of some 20 countries in the world (95% of Group’s employees) 3 plans implemented since spin-off in 2006 ● 2008 shar

  39. Slide 39: Ambition 2016

    Ambition 2016

  40. Slide 40: Our roadmap to 2016

    Our roadmap to 2016 « Become a world leader in specialty chemicals and advanced materials » Deliver profitable growth and solid cash flow Accelerate development of High Performance Materials Intensify our presence in high growth countries (China, India, Brazil, Middle East) Increase downstream integ

  41. Slide 41: 2016 financial targets

    2016 financial targets € 8 bn 16 % Sales EBITDA margin EBITDA (€m) 1,280 996 + 140 + 144 Acquisitions and < 40 % Organic growth divestments Gearing 2012 2016e 41

  42. Slide 42: Accelerate expansion in High Performance Materials

    Accelerate expansion in High Performance Materials Polymers pyramid Sales by segment Arkema well positioned on high end € 8 bn PEKK (under technical development) € 6.4 bn PVDF 38% + € 0.9 bn Polyamide 11 Polyamide 10 Polyamide 12 High Performance 33% Materials PMMA composite PMMA Industrial 30% Spec

  43. Slide 43: Development in high growth countries

    Development in high growth countries Sales by region (€bn) North America Europe € 8 bn Asia and RoW 2.5 2.8 € 6.4 bn 2.8 2.4 30% 2.2 1.7 Asia and RoW 26% North America 35% 34% 2012 2016e 2012 2016e 2012 2016e Europe 40% 35% 2012 2016e 43

  44. Slide 44: 2016 targets by segment

    2016 targets by segment High Performance Materials 38% of total sales 18% EBITDA margin Industrial Specialties 30% of total sales 17% EBITDA margin Coating Solutions 32% of total sales 15% EBITDA margin 44

  45. Slide 45: Start up of industrial projects

    Start up of industrial projects 2012 2013 2014 ● 2EHA ● Acrylic acid and esters ● Thiochemical platform (United States) (United States) (Malaysia) ● PVDF expansion ● Hipro expansion (x3) (China) (China) ● HFC125 expansion ● Coating resins (China) (China) Several projects ● ADAME ● Superabsorbents *

  46. Slide 46: A promising R&D projects pipeline

    A promising R&D projects pipeline Today Short-medium term Longer term PVDF for Electrolytes for Li-sulfur batteries Li-ion batteries Li-ion batteries (Oxis) New energies PVDF film for LGWP Thin layer solar panel Fluorogases photovoltaic Metathesis process Renewable PMMA RNew® PA11/ PA10 Acrylic acid

  47. Slide 47: Cash allocation over 2013-2016

    Cash allocation over 2013-2016 € 3.6 bn cash resources available Capex Cumulative cash Borrowing flow from capacity € 1.7 bn operations M&A, dividends and others € 1.9 bn M&A Dividends Others 47

  48. Slide 48: 2020 targets

    2020 targets Sales (€bn) EBITDA and EBITDA margin (%) Close to 16% 17% 15.6% 10 8 6.4 6% 5.7 2005 2012 2016e 2020e 2005 2012 2016e 2020e Gearing < 40% 48

  49. Slide 49: Disclaimer

    Disclaimer The information disclosed in this document may contain forward-looking statements with respect to the financial condition. results of operations. business and strategy of Arkema. Such statements are based on management’s current views and assumptions that could ultimately prove inaccurate

Arkema — Shareholder Meeting (June 2013) on 6ix